| β-arrestin–dependent activation of the cofilin pathway is required for the scavenging activity of the atypical chemokine receptor D6 EM Borroni, C Cancellieri, A Vacchini, Y Benureau, B Lagane, ... Science signaling 6 (273), ra30-ra30, 2013 | 95* | 2013 |
| The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33 M Liguori, E Digifico, A Vacchini, R Avigni, FS Colombo, EM Borroni, ... Cellular & molecular immunology 18 (3), 711-722, 2021 | 79 | 2021 |
| Overview and potential unifying themes of the atypical chemokine receptor family A Vacchini, M Locati, EM Borroni Journal of Leucocyte Biology 99 (6), 883-892, 2016 | 70 | 2016 |
| Atypical chemokine receptors: from silence to sound C Cancellieri, A Vacchini, M Locati, R Bonecchi, EM Borroni Biochemical Society Transactions 41 (1), 231-236, 2013 | 53 | 2013 |
| MR1-restricted T cells are unprecedented cancer fighters A Vacchini, A Chancellor, J Spagnuolo, L Mori, G De Libero Frontiers in immunology 11, 751, 2020 | 38 | 2020 |
| Differential effects of posttranslational modifications of CXCL8/interleukin-8 on CXCR1 and CXCR2 internalization and signaling properties A Vacchini, A Mortier, P Proost, M Locati, M Metzemaekers, EM Borroni International Journal of Molecular Sciences 19 (12), 3768, 2018 | 20 | 2018 |
| Pituitary adenoma and the chemokine network: a systemic view F Grizzi, EM Borroni, A Vacchini, D Qehajaj, M Liguori, S Stifter, ... Frontiers in Endocrinology 6, 141, 2015 | 20 | 2015 |
| Structure–function and biological properties of the atypical chemokine receptor D6 C Cancellieri, N Caronni, A Vacchini, B Savino, EM Borroni, M Locati, ... Molecular immunology 55 (1), 87-93, 2013 | 19 | 2013 |
| Endogenous modification of the chemoattractant CXCL5 alters receptor usage and enhances its activity toward neutrophils and monocytes M Metzemaekers, A Mortier, A Vacchini, D Boff, K Yu, R Janssens, ... Science Signaling 14 (673), eaax3053, 2021 | 15 | 2021 |
| Control of cytoskeletal dynamics by β-arrestin1/myosin Vb signaling regulates endosomal sorting and scavenging activity of the atypical chemokine receptor ACKR2 A Vacchini, C Cancellieri, S Milanesi, S Badanai, B Savino, F Bifari, ... Vaccines 8 (3), 542, 2020 | 12 | 2020 |
| MR1, an immunological periscope of cellular metabolism A Chancellor, A Vacchini, G De Libero International Immunology 34 (3), 141-147, 2022 | 9 | 2022 |
| Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome R Kumar, S Milanesi, M Szpakowska, L Dotta, D Di Silvestre, AM Trotta, ... JCI insight 8 (5), 2023 | 8 | 2023 |
| Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses A Chancellor, RA Simmons, RC Khanolkar, V Nosi, A Beshirova, ... The Journal of experimental medicine 220 (9), 2023 | 7 | 2023 |
| Analysis of G Protein and β-Arrestin Activation in Chemokine Receptors Signaling A Vacchini, M Busnelli, B Chini, M Locati, EM Borroni Methods in enzymology 570, 421-440, 2016 | 5 | 2016 |
| Nucleobase adducts bind MR1 and stimulate MR1-restricted T cells A Vacchini, A Chancellor, Q Yang, R Colombo, J Spagnuolo, G Berloffa, ... Science Immunology 9 (95), eadn0126, 2024 | 2 | 2024 |
| Nucleobase adduct-containing metabolites are MR1 ligands that stimulate self-reactive MR1T cells A Vacchini, Q Yang, A Chancellor, J Spagnuolo, D Joss, O Øyås, ... BioRxiv, 2022.08. 26.505411, 2022 | 2 | 2022 |
| Isolation and characterization of MAIT cells from human tissue biopsies D Di Blasi, A Vacchini, G De Libero, L Mori MAIT Cells: Methods and Protocols, 23-38, 2020 | 2 | 2020 |
| Mr1 ligands and pharmaceutical compositions for immunomodulation G De Libero, L Mori, A Vacchini, A Chancellor, J Spagnuolo, Y Qinmei US Patent App. 17/793,419, 2023 | 1 | 2023 |
| Phosphoproteomic mapping of CCR5 and ACKR2 signaling properties A Vacchini, E Maffioli, D Di Silvestre, C Cancellieri, S Milanesi, S Nonnis, ... Frontiers in Molecular Biosciences 9, 1060555, 2022 | 1 | 2022 |
| MR1 gene and protein expression are enhanced by inhibition of the extracellular signal-regulated kinase ERK D Constantin, V Nosi, N Kehrer, A Vacchini, A Chancellor, E Contassot, ... Cancer Immunology Research, OF1-OF16, 2024 | | 2024 |
